Target intelligence / Profile preview

Retinoic acid receptor responder 2 pseudogene 5 (RARRES2P5)

Target: RARRES2P5
Molecular classification: Pseudogene, processed pseudogene

Overview

Retinoic acid receptor responder 2 pseudogene 5 (RARRES2P5) is a human processed pseudogene, meaning it originated from retrotransposition of mRNA and subsequent integration into the genome. Unlike its parental gene, RARRES2 (encoding chemerin, a protein involved in inflammation and metabolism), RARRES2P5 does not encode a functional protein. Pseudogenes may sometimes have RNA-level functions, such as regulating gene expression through antisense transcripts or by acting as miRNA sponges, but no specific function has been described for RARRES2P5. It is not considered a therapeutic target or biomarker, and no drugs interact with it[1][2][3][5][7].

Other names: retinoic acid receptor responder (tazarotene induced) 2 pseudogene 5RARRES2P5

Mechanism of action

None (no drug mechanism since no functional product)

Biological functions

Possible RNA-level regulatory function typical for some pseudogenes (e.g., acting as competitive endogenous RNAs, miRNA decoys, or antisense regulators), but no evidence for protein function

Disease associations

No documented direct implication in human disease; processed pseudogenes can sometimes regulate disease-relevant genes at the RNA level, but no data for RARRES2P5 specifically

Beyond the preview

Go deeper on Retinoic acid receptor responder 2 pseudogene 5 (RARRES2P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoic acid receptor responder 2 pseudogene 5 (RARRES2P5).

Explore the full profile